Literature DB >> 19218858

Prognostic significance of stromal eosinophilic infiltration in oral squamous cell carcinoma.

Azadeh Andisheh Tadbir1, Mohammad Javad Ashraf, Yasaman Sardari.   

Abstract

Tumor-associated tissue eosinophilia (TATE) has been described in many sites, including head and neck. The aim of this study was to investigate the prevalence and possible role of TATE as a prognostic factor in oral squamous cell carcinoma (OSCC). Seventy-six consecutive patients with a diagnosis of OSCC were evaluated, and the number of eosinophils was obtained in 3 different areas in the tumor. The possible role of TATE as a prognostic factor in OSCC was investigated with respect to tumor differentiation; perineural, vascular, and muscular invasion (histopathologic parameters); and locoregional metastasis (clinical parameter). Tumor-associated tissue eosinophilia was low in most cases in 3 different areas. The mean eosinophil count was higher in the invasive front of tumor than intratumoral stroma and stroma subjacent the surface epithelium. The relations between TATE and tumor differentiation; perineural, vascular, and muscular invasion; and locoregional metastasis were not statistically significant (P > 0.05). Tumor-associated tissue eosinophilia has no correlation with prognostic parameters in OSCC.

Entities:  

Mesh:

Year:  2009        PMID: 19218858     DOI: 10.1097/SCS.0b013e318199219b

Source DB:  PubMed          Journal:  J Craniofac Surg        ISSN: 1049-2275            Impact factor:   1.046


  17 in total

1.  Eosinophils may predict occult lymph node metastasis in early oral cancer.

Authors:  D T Oliveira; T P Biassi; S E S Faustino; A L Carvalho; G Landman; L P Kowalski
Journal:  Clin Oral Investig       Date:  2011-12-14       Impact factor: 3.573

2.  Quantitative Evaluation of Tumour--Associated Tissue Eosinophilia and Cyclo-oxegenase-2 Gene in Oral Cancer Patients with Assessment of Long Term Outcomes.

Authors:  N Rakesh; Asha Iyengar; Kuhu Majumdar; G S Vidya; S S Shantha Kumar
Journal:  Pathol Oncol Res       Date:  2015-11-17       Impact factor: 3.201

Review 3.  Will the mininvasive approach challenge the old paradigms in oral cancer surgery?

Authors:  G Tirelli; S Zacchigna; F Boscolo Nata; E Quatela; R Di Lenarda; M Piovesana
Journal:  Eur Arch Otorhinolaryngol       Date:  2016-08-04       Impact factor: 2.503

4.  Primary esophageal sclerosing mucoepidermoid carcinoma with "tissue eosinophilia".

Authors:  Suman Mewa Kinoo; Kapil Maharaj; Bhugwan Singh; Michelle Govender; Pratistadevi Kanaye Ramdial
Journal:  World J Gastroenterol       Date:  2014-06-14       Impact factor: 5.742

5.  Tumor-associated tissue eosinophilia as a prognostic factor in squamous cell carcinoma of the larynx.

Authors:  D Etit; B G Yardım; S Arslanoğlu; U Bayol; I Cukurova; S Oztürkcan; N Ş Korkmaz
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2011-12-15

Review 6.  Immune suppression in head and neck cancers: a review.

Authors:  Anaëlle Duray; Stéphanie Demoulin; Pascale Hubert; Philippe Delvenne; Sven Saussez
Journal:  Clin Dev Immunol       Date:  2011-03-10

7.  Tumour associated tissue eosinophilia as a predictor of locoregional recurrence in oral squamous cell carcinoma.

Authors:  Nagaraju Rakesh; Yashoda Devi; Kuhu Majumdar; Sujatha S Reddy; Kunal Agarwal
Journal:  J Clin Exp Dent       Date:  2015-02-01

8.  Eosinophils and oral squamous cell carcinoma: a short review.

Authors:  C P Martinelli-Kläy; B R R N Mendis; T Lombardi
Journal:  J Oncol       Date:  2009-12-16       Impact factor: 4.375

Review 9.  Tumour-associated tissue eosinophilia (TATE) in oral squamous cell carcinoma: a comprehensive review.

Authors:  Marco Mascitti; Lucrezia Togni; Corrado Rubini; Giuseppe Troiano; Lorenzo Lo Muzio; Andrea Santarelli
Journal:  Histol Histopathol       Date:  2020-09-28       Impact factor: 2.303

10.  Trial watch: Prognostic and predictive value of the immune infiltrate in cancer.

Authors:  Laura Senovilla; Erika Vacchelli; Jerome Galon; Sandy Adjemian; Alexander Eggermont; Wolf Hervé Fridman; Catherine Sautès-Fridman; Yuting Ma; Eric Tartour; Laurence Zitvogel; Guido Kroemer; Lorenzo Galluzzi
Journal:  Oncoimmunology       Date:  2012-11-01       Impact factor: 8.110

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.